Michal Sarfaty

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer

Raz Mutai, Tamar Barkan, Assaf Moore et al. · The Breast · 2021 · 132 citations · Full text

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

Michal Sarfaty, Moshe Leshno, Noa Gordon et al. · European Urology · 2017 · 66 citations

Urology, Genitourinary Cancer, Medicine +3

Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer

Michal Sarfaty, Peter Hall, Kelvin Chan et al. · European Urology · 2018 · 66 citations · Full text

Oncology, Urology, Medicine +1

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma

Assaf Moore, Michal Cohen‐Naftaly, Anna Tobar et al. · Radiation Oncology · 2017 · 65 citations · Full text

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Brendan J. Guercio, Michal Sarfaty, Min Yuen Teo et al. · Clinical Cancer Research · 2023 · 55 citations · Full text